Atlas Trials

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Clinical trial NCT01979380 · COMPLETED

Trial details

NCT number
NCT01979380
Sponsor
Kwang Dong Pharmaceutical co., ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Toxicity
Start date
2013-12-01
Primary completion
2014-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.